Peregrine to Report Fourth Quarter and Year-End Fiscal Year 2013 Financial Results After Market Close on July 11, 2013 (Peregrine Pharmaceuticals Inc)

(Source: Peregrine Pharmaceuticals Inc) TUSTIN, CA -- (Marketwired) -- 07/02/13 -- Peregrine Pharmaceuticals, Inc. (NASDAQ: PPHM), a clinical-stage biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced that it will report financial results for the fourth quarter and fiscal...